In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season
In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan
Ikematsu H., Kawai N., Iwaki N., Kashiwagi S. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan. J Infect Chemother 2012, 18:529-533.
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan
Ikematsu H., Kawai N., Iwaki N., Kashiwagi S. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan. J Infect Chemother 2014, 20:77-80.
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season
Ikematsu H., Kawai N., Iwaki N., Kashiwagi S. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season. J Infect Chemother 2015, 21:39-42.
Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages
Nakauchi M., Takayama I., Takahashi H., Oba K., Kubo H., Kaida A., et al. Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages. J Virol Methods 2014, 205:110-115.
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity
Yamashita M., Tomozawa T., Kakuta M., Tokumitsu A., Nasu H., Kubo S. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother 2008, 53:186-192.
Meeting of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012
World Health Organization Meeting of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012. Wkly Eepidemiol Rec 2012, 39:369-380.
A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons
Kawai N., Ikematsu H., Iwaki N., Maeda T., Satoh I., Hirotsu N., et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006, 43:439-444.
The duration of fever and other symptoms after the initiation of Laninamivir Octanoate Hydrate in the Japanese 2011-2012 influenza season
Ikematsu H., Kawai N., Iwaki N., Kashiwagi S. The duration of fever and other symptoms after the initiation of Laninamivir Octanoate Hydrate in the Japanese 2011-2012 influenza season. J Infect Chemother 2014, 20:81-85.
Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: comparison between the 2011-2012 and 2012-2013 influenza seasons
Ikematsu H., Kawai N., Iwaki N., Kashiwagi S. Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: comparison between the 2011-2012 and 2012-2013 influenza seasons. J Infect Chemother 2014, 20:799-803.